ARIAD Pharma (ARIA) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.78 -0.96%
Financial Fact:
License and collaboration revenue: 11.72M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
License and collaboration revenue: 11.72M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.28), $0.02 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $23.9 million versus the consensus estimate of $27.26 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
